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Abstract
Background: Patients after primary hip or knee replacement surgery can benefit from postoperative treatment in
terms of improvement of independence in ambulation, transfers, range of motion and muscle strength. After
discharge from hospital, patients are referred to different treatment destination and modalities: intensive inpatient
rehabilitation (IR), cure (medically prescribed stay at a convalescence center), or ambulatory treatment (AT) at home.
The purpose of this study was to 1) measure functional health (primary outcome) and function relevant factors in
patients with hip or knee arthroplasty and to compare them in relation to three postoperative management strategies:
AT, Cure and IR and 2) compare the post-operative changes in patient’s health status (between preoperative and the
6 month follow-up) for three rehabilitation settings.
Methods: Natural observational, prospective two-center study with follow-up. Sociodemographic data and functional
mobility tests, Timed Up and Go (TUG) and Iowa Level of Assistance Scale (ILOAS) of 201 patients were analysed before
arthroplasty and at the end of acute hospital stay (mean duration of stay: 9.7 days +/− 3.9). Changes in health
state were measured with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) before
and 6 months after arthroplasty.
Results: Compared to patients referred for IR and Cure, patients referred for AT were significantly younger and
less comorbid. Patients admitted to IR had the highest functional disability before arthroplasty. Before rehabilitation,
mean TUG was 40.0 s in the IR group, 33.9 s in the Cure group, and 27.5 s in the AT group, and corresponding mean
ILOAS was 16.0, 13.0 and 12.2 (50.0 = worst). At the 6 months follow-up, the corresponding effect sizes of the WOMAC
global score were 1.32, 1.87, and 1.51 (>0 means improvement).
Conclusions: Age, comorbidity and functional disability are associated with referral for intensive inpatient rehabilitation
after hip or knee arthroplasty and partly affect health changes after rehabilitation.
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Background
Joint replacement surgery is a routine treatment for ad-
vanced osteoarthritis of the hip and knee. The primary
treatment goal is the restoration of independence in the
activities of daily life by reduction of pain and disabil-
ity [1]. Arthroplasty is one management option recom-
mended by the European League against Rheumatism
(EULAR) alongside medication, exercise therapy and
patient education [2, 3]. Health-related quality of life
was observed to be improved after arthroplasties of the
hip and knee [4–7].
From 2005 to 2008 the number of implanted hip and
knee arthroplasties in Switzerland increased from 238 to
262, and from 140 to 177 respectively per 100,000 in-
habitants per year [8]. In 2011, 306 hip and 205 knee re-
placement surgeries per 100,000 citizens were performed
in Switzerland [9].
Postoperative management directly after hip or knee
arthroplasty in the acute hospital includes physiotherapy
which is, in most countries, accepted as standard treat-
ment. The main focus of physiotherapeutic treatment is
on mobilization on the first or second postoperative day,
walking instruction with crutches according to the weight
bearing restrictions depending on the fixation of the im-
plants and on individual surgeons’ preferences, as well as
minimization of complications (e.g. wound infection, deep
vein thrombosis or pulmonary embolism) [1, 10–12]. The
prevention of hip dislocation and the focused improve-
ment on range of motion after knee arthroplasty are add-
itional, joint-specific aims of physiotherapeutic treatment
in hospital [10, 12].
In Switzerland, physiotherapeutic and medical treat-
ment generally continue after discharge from the acute
care hospital to different inpatient or outpatient settings.
Patients may be discharged home with ambulatory med-
ical and physiotherapeutic treatment (AT). This outpatient
treatment may take place, according to the patient’s pref-
erence, at home (home-based), in an outpatient treatment
setting or in an outpatient clinic. More intense treatment
options include the medically prescribed stay at a con-
valescence center (Cure) or inpatient rehabilitation (IR)
in a specialized orthopedic rehabilitation clinic provid-
ing 24 h of medical care.
The decision where to refer the patient for post-hospital
care is made by the surgeon in consultation with the pa-
tient. Insurance companies are asked to grant payment for
IR or Cure based on a detailed description of the patient’s
medical record by the surgeon. Age, comorbidities, so-
cial situation at home and dependence on nursing sup-
port in the hospital are supposed to be taken into
consideration and included in the report for the insur-
ance company. Immobility and lack of social support at
home may require more intensive inhouse treatment.
Whether these decision-making factors are really applied
in clinical reality is unclear and empirically not proven.
However, there are no evidence-based criteria such as a
threshold score from a functional assessment that facili-
tates the decision-making process with regard to the fu-
ture direction of post-hospital care. The post-acute phase
of rehabilitation is less well documented and researched
than the acute care phase, but includes therapeutic exer-
cise (joint mobilization, muscle strengthening), transfer
and gait training as well as instruction of the activities of
daily living [11, 12].
The first aim of this study was to measure functional
health (primary outcome) and function relevant factors
in patients with hip or knee arthroplasty and to compare
them in relation to three postoperative management
strategies: AT, Cure and IR. The first hypothesis was that
older, more immobile patients with a higher number of
comorbidities who are living alone are more likely to be
referred to IR than to Cure or AT. Further, we analysed
the changes in health observed after the three different
rehabilitation settings. The second hypothesis was that
higher score changes were expected in the IR group
followed by the Cure group and the lowest score
changes in the AT group. In other words, therapy inten-
sity was expected to be positively associated to the size
of the score changes. To the best of our knowledge,
there are no studies that have analysed the relationship
between these rehabilitation settings and the change of
health state in patients with hip or knee arthroplasty.
Methods
Patients
Patients were recruited at the Cantonal Hospital of St.
Gallen (KSSG) and at the Inselspital (ISB), Bern Univer-
sity Hospital in Berne, Switzerland. In the Departments
of Orthopedics, patients with hip or knee osteoarthritis
who were referred to the hospitals for primary hip or
knee arthroplasty by their family physician or rheuma-
tologist were consecutively invited to participate in the
study. Patients of 50 years of age or older were included
if they were scheduled for a primary total or partial
arthroplasty. Exclusion criteria included insufficient Ger-
man language skills to complete the questionnaires and
refusal to participate in the study. During follow-up pa-
tients were excluded it they refused further participation,
did not return the questionnaires or if their question-
naires were incomplete according to the missing rules of
the Western Ontario and McMaster Universities Osteo-
arthritis Index (WOMAC) [13].
For sample size calculation of differences of score
changes between two groups, a t-test formula was used
setting type one error to alpha = 0.05 and type two error,
beta = 0.20 (power = 0.80). We assumed a standard devi-
ation of 20 score points of the score differences between
baseline and follow-up for each group and difference of
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the score differences (each between baseline and follow-
up) of 8 score points. This corresponds to a standardized
mean difference of 0.40 which is the size of an effect that
has been determined as minimally clinically important
(perceptive for the patients) for the WOMAC global
score [14]. This leads to a minimal total sample size for
the two examined groups of n = 100 for each of the pair-
wise group comparisons.
Written informed consent was obtained from all par-
ticipants. The cantonal ethic committees of Bern and St.
Gallen, to which the study protocol was submitted, clas-
sified this study protocol as “no risk” and confirmed that
no project approval needed to be granted.
Intervention
In this natural observational, prospective two-center
study, pre- and postoperative treatments as well as sur-
gery were conducted according to the standard treat-
ment protocol of the Cantonal Hospital of St. Gallen
(KSSG) and the Inselspital (ISB), Bern University Hos-
pital in Bern, Switzerland. These protocols included pre-
operative treatment in the hospital with information
about surgery and physiotherapeutic instruction about
postoperative proceedings including instruction about
postoperative prevention of pneumonia, technique of
mobilization and walking with crutches.
Post-hospital rehabilitative treatment after hip or knee
arthroplasty included IR, Cure and AT. These rehabilita-
tive interventions optimize surgical outcomes by redu-
cing pain, improving strength and function and by
minimization of complications. There is insufficient sci-
entific evidence about the precise rehabilitative and
therapeutic techniques that should be applied. In gen-
eral, treatment is led by the type and severity of the
symptoms presented at the medical examination at ad-
mission to rehabilitation as well as by the recommenda-
tions of the surgeon. Therefore, the individual treatment
in this naturalistic study was not standardized or
accounted for in the analysis.
The intensity of treatment was defined by the type of
rehabilitation prescribed by the surgeon. Benefits are
granted in accordance with the Swiss Federal Health In-
surance Act. In Switzerland, a medical prescription for
ambulatory physiotherapeutic treatment (AT) includes a
maximum of 30 min of treatment by a trained physio-
therapist two to three times a week for 9 sessions and
medical treatment by a doctor when required.
A medically prescribed stay at a convalescence center
(Cure) includes 1 to 2 therapy units of 30 min per day.
The Swiss health insurance companies grant full pay-
ment for medical consultations, medication and therap-
ies as prescribed. A daily contribution to lodging (€ 10)
for a maximum of 21 days per year is paid by the
mandatory basic insurance according to the Swiss Federal
Health Insurance Act. Additional therapies, medical ser-
vices and a higher contribution to lodging may be paid by
an optional supplementary health care insurance or by the
patient. During Cure, patients may lodge in a specialized
convalescence hotel (health resort or spa hotel) or in a
hotel close to a rehabilitation clinic, where they attend
medical consultations and prescribed therapies. Com-
pared to IR, Cure does not provide permanent medical
care (24 h of permanent medical and nursing care) and
cost for accommodation is not fully covered by the
mandatory basic insurance.
For a more intense inhouse rehabilitation (IR in the
following) in accordance with the Swiss Federal Health
Insurance Act, the rehabilitation facility has to be quali-
fied by the public health authority to provide musculo-
skeletal rehabilitation. If the requirement of medical care
and rehabilitation for a patient was confirmed by the pa-
tient’s insurance company, commitment to cover costs is
granted for 2 to 3 weeks based on a fixed daily rate, in-
cluding medical and nursing services as well as full
coverage of board and lodging. Therapeutic measures in-
clude 3 to 4 therapy sessions of different type according
to the medical prescription of the medical doctor in
charge: physical therapy, group therapies, thermal appli-
cations a.o.
Measures
Socio-demographic and potentially confounding parame-
ters, such as sex, age, living alone, smoking, alcohol con-
sumption, sports, and formal education were recorded
on a standardized form at admission to the hospital (T0)
[15]. Comorbidities (excluding joint diseases) were re-
corded on the Self-administered Comorbidity Question-
naire (SCQ) and by review of the medical records [16].
Symptoms and activities were assessed using the
WOMAC. This is a disease-specific multidimensional
self-assessment instrument for osteoarthritis of the
lower extremity measuring pain (5 items), stiffness (2
items) and physical functional ability (17 items) leg-
but not joint-specifically [13]. All 24 items were evalu-
ated on a continuous visual analogue scale ranging
from ‘no symptoms/no limitation’ to ‘maximal symp-
toms/maximal limitation’. The validated German ver-
sion was used [17]. According to the missing rule of
the user’s guide, the subscores can only be determined if
at least 4 of the 5 pain items, 1 of the 2 stiffness items,
and 14 of the 17 function items are completed [13].
The Iowa Level of Assistance Scale (ILOAS) is a func-
tional outcome and mobility instrument developed for
patients after joint replacement [18]. It requires that five
functional activity tests are performed in the following
defined order: transfer from supine to sitting, stand up
from the bed (transfer from sitting to standing), walk
4.57 m (15 ft), climb up and down three steps, walking
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speed over a distance of 13.4 m (44 ft). The first four
tasks are graded according to the level of assistance re-
quired on a scale from 0 (independent) to 6 (not tested
for safety reasons). The assistance device used in tasks
that involve standing or mobilization is scaled from 0
(no assistance device) to 5 (walking frame or rollator).
The ambulation velocity is rated on an ordinal scale
from 0 (≤20 s) to 6 (>70 s). The total score is calculated
and ranges from 0 (independence in all tasks and no as-
sistive device required) to 50 (for medical reasons or
safety reasons unable to perform any of the five tasks
and using a walking frame or rollator as an assistive de-
vice). After total hip or knee replacement, assessing the
functional outcome with ILOAS was reliable, valid and
responsive [18, 19].
The “Timed Up and Go” (TUG) is a modified, timed
version of the “Get-Up and Go” test first described by
Mathias et al. [20]. It is a simple and inexpensive
method to assess basic mobility with everyday move-
ments [21]. Time is measured while the following basic
functional mobility tasks are performed in the following
sequence: getting up from a chair (seat height 46 cm)
with arm rest, walk 3 m, turn around, walk back and sit
down again [22]. The TUG was shown to be responsive
in detecting improvements after arthroplasties in the
early postoperative phase [23].
Analyses
Primary outcome measure was the change in WOMAC
score assessed at admission to the hospital (T0) prior to
surgery and at follow-up at 6 months post-surgery (T2).
For the use of the WOMAC, licensing processes and
costs had to be paid based on the specific information
about the research project. To reduce costs, the WOMAC
was not administered at T1. Further assessment at T0 in-
cluded sociodemographic data, comorbidities, TUG and
ILOAS. Functional assessments, TUG and ILOAS, were
measured for the second time after arthroplasty (T1) in
the hospital (mean duration of stay: 9.7 days +/− 3.9).
These measures of functional mobility were used to ana-
lyse a possible relation to the different rehabilitation set-
tings. Since they were not used as outcome measures,
TUG and ILOAS were only assessed at T0 and T1. At T2,
the functional tests were not performed due to expenses
and inconveniences for the patients for travelling back to
the hospital for the examination. Follow-up at 6 months
post-surgery included in addition to the WOMAC score
the discharge destination after hospital and information
about post-hospital treatment (T2).
All WOMAC scores were transformed into a scale
ranging from 0 (“no symptoms/no limitation”) to 100
(“maximal symptoms/maximal limitation”) to facilitate
comparison of the descriptive data [24]. Standardized
effect sizes were calculated to obtain a quantification of
the score changes or “effects” of the intervention [25].
Effect sizes (ES) of 0.00 – 0.19 reflect very small, 0.20–
0.49 small, 0.50–0.79 moderate, and 0.80 or more large
improvement [26]. A positive ES reflects a health
improvement.
Statistical significance between the independent post-
hospital treatment groups, functional mobility measures
and WOMAC scores were analysed pairwise by the non-
parametric Mann–Whitney-U- test and the Pearson
Chi-square test. The comparison between two groups
only was chosen in favor of more detailed statistical in-
formation about the differences between groups and to
optimise interpretation of significant differences. The co-
morbidities were quasi continuous and were, therefore,
analysed with the Wilcoxon signed-rank test. The level
of statistical significance was set at the 95 % confidence
level (p < 0.050).
All analyses were performed using the statistical
software package SPSS 20.0 for Windows (SPSS Inc.,
Chicago, IL, USA).
Results
Patients
A total of 221 patients were recruited for this study from
February to December 2010. 177 patients (80 %) were
included to the study at the Cantonal Hospital of St.
Gallen (KSSG) and 44 (20 %) at the Inselspital (ISB),
Bern University Hospital in Bern, Switzerland. 109 pa-
tients (49 %) were operated at the knee unilaterally, 99
(45 %) at the hip unilaterally. All others were operated at
the hips or knees bilaterally and one person had a com-
bined operation of hip and knee. 20 patients (9 %) had
to be excluded for reasons of non-compliance. Of the
remaining 201 patients, the number of complete data sets
is indicated in the tables.
Socio-demographic variables and disease-relevant char-
acteristics as well as the characteristics of the different
treatment groups are presented in Table 1. Significant dif-
ferences were found between AT and Cure as well as be-
tween AT and IR in the categories age and living. The
comorbidities differed significantly between the AT and IR
group. Patients treated in an ambulatory, outpatient set-
ting were significantly younger than the patients treated in
Cure (p = 0.029) or IR (p = 0.001). Patients living with a
partner or children were significantly more often referred
to AT than to Cure (p = 0.043) or to IR (p = 0.033). The
larger proportion of patients referred to Cure was female
(67 %) whereas half of the patients in the AT group were
male (p = 0.045).
All other categories of socio-demographic variables
and disease-relevant characteristics between the three
patient groups shown in Table 1 do not differ signifi-
cantly between groups.
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Functional mobility measures
The functional mobility measures at admission to and be-
fore discharge from the hospital are shown in Table 2. In
all rehabilitation groups, the time for the TUG and the
ILOAS score increased from T0 at admission to hospital
to T1 after arthroplasty. This means that the patients had,
on average, a decrease in function in the first phase after
their joint surgery. At admission to the hospital and before
surgery (T0), the Cure group had the lowest TUG time
and ILOAS score (reflecting the best function). After the
operation, TUG time and ILOAS score were lowest in the
AT group (27.5 s, 12.2 score points respectively), higher in
the Cure group (33.9 s, 13.9 respectively) and highest in
the IR group (40.0 s, 16.0 respectively).
Significant differences were measured between AT and
IR in both measures at T0 (TUG p = 0.040, ILOAS p =
0.020) and at T1 (TUG p = 0.001, ILOAS p < 0.001). All
other calculations comparing the functional mobility
measures at T0 and T1 were not statistically significant.
WOMAC scores
WOMAC scores at admission and at follow-up as well
as the statistical analysis are shown in Table 3. In gen-
eral, independent of the post-hospital treatment desti-
nations, the global score of WOMAC as well as in the
subscales of pain, stiffness and function improved. The
improvements ranged between ES = 0.95 (stiffness, AT)
and ES = 1.87 (global score, Cure) reflecting large
Table 1 Patient’s demographic and clinical characteristics at entry to the hospital (T0)
Ambulatory
treatment (AT)
Cure Inpatient
rehabilitation (IR)
p p p
n = 93 (46.3 %) n = 46 (22.9 %) n = 62 (30.8 %) AT vs. Cure AT vs. IR Cure vs. IR
Age (y) 65 (+/− 11) 70 (+/− 9) 71 (+/− 8) 0.029* 0.001* 0.391
Sex (%) Female 46 (50 %) 31 (67 %) 37 (60 %) 0.045* 0.212 0.412
Living (%) Alone 16 (17 %) 15 (33 %) 20 (32 %) 0.043* 0.033* 0.969
With partner
or Children
76 (82 %) 31 (67 %) 42 (68 %)
Smoking (%) Yes 15 (16 %) 3 (7 %) 5 (8 %) 0.112 0.142 0.762
Alcohol consumption (%) No 30 (32 %) 9 (20 %) 19 (31 %) 0.232 0.384 0.227
Sometimes 48 (52 %) 30 (67 %) 31 (50 %)
Daily 12 (13 %) 6 (13 %) 12 (19 %)
Several times
per day
3 (3 %) 0 (0 %) 0 (0 %)
Sports (%) None 35 (38 %) 12 (26 %) 21 (37 %) 0.286 0.108 0.384
<1 h/week 15 (16 %) 5 (11 %) 4 (7 %)
1 – 2 h/week 22 (24 %) 13 (28 %) 10 (18 %)
>2 h/week 21 (23 %) 16 (35 %) 22 (39 %)
Comorbidities (%) None 35 (38 %) 19 (41 %) 16 (26 %) 0.962 0.022* 0.059
1 34 (37 %) 11 (24 %) 15 (24 %)
2 10 (11 %) 12 (26 %) 19 (31 %)
>2 14 (14 %) 4 (9 %) 12 (19 %)
Joint (%) Hip unilateral 45 (49 %) 22 (48 %) 22 (35 %) 0.856** 0.188** 0.343**
Knee unilateral 46 (49 %) 24 (52 %) 31 (50 %)
Hip bilateral 1 (1 %) 0 (0 %) 1 (2 %)
Knee bilateral 1 (1 %) 0 (0 %) 7 (11 %)
Hip and knee 0 (0 %) 0 (0 %) 1 (2 %)
Education (%) Basic school
(8–9 years)
23 (25 %) 11 (24 %) 17 (27 %) 0.882 0.597 0.821
Vocational training 48 (52 %) 25 (54 %) 34 (55 %)
College/high school 11 (12 %) 7 (15 %) 6 (12 %)
University 9 (10 %) 3 (7 %) 5 (7 %)
Age is the arithmetic mean (+/− standard deviation), all other values are n with the corresponding % at T0 (=admission to hospital). AT ambulatory treatment, IR
inpatient rehabilitation, h/week hours per week, *statistical significance with p < 0.050, **statistical calculation only with two groups: hip and knee (i.e., not
specified whether uni- or bilateral)
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effects for all dimensions. The Cure group had the
highest WOMAC scores in pain (47.9), stiffness (47.7)
and function (49.4) as well as in the global WOMAC
score (48.9) prior to the arthroplasty. After the oper-
ation, the same group showed the largest reductions in
scores, respectively largest improvements with effect
sizes from 1.35 (stiffness) to 1.87 (global score). The
subscore of stiffness showed the smallest improvements
in all rehabilitation groups when compared to the sub-
scores of pain and function.
There was no general difference in the health state of
the three rehabilitation groups prior to hip or knee
arthroplasty (data not shown). Prior to surgery (at T0),
there was a statistically significant difference in the glo-
bal score (p = 0.017) and the subscore of function (p =
0.022) between the AT and the Cure group. Postopera-
tively (T2), Cure patients showed significantly higher im-
provements in pain (p = 0.036) and in the global score
(p = 0.037) of WOMAC than the AT group. All other di-
mensions (AT vs. Cure) and the other differences be-
tween AT and IR as well as Cure and IR, respectively,
were not statistically significant.
Associations of cofactors to disability at baseline
Disability at baseline (T0) was associated to mobility at
baseline (TUG: explained variance 12.5 %, p < 0.001) and
to number of comorbidities (explained variance 2.3 %, p =
0.027), but not to living with partner/alone (p = 0.262).
However, the whole model showed low fit with explained
variance of 14.7 %.
Discussion
This natural, observational two-center study analysed
the functional status and the socio-demographic, disease-
relevant factors in patients before and immediately after
hip or knee arthroplasty in relation to three different re-
habilitation settings. The first hypothesis was confirmed,
i.e. older patients with more comorbidities and preopera-
tively worse mobility status who were living alone were
postoperatively more likely to be referred to an intensive
inpatient rehabilitation clinic. The differences between IR
and AT were largest and statistically significant. However,
the differences in functional tests (TUG and ILOAS) be-
fore surgery between AT and Cure were small and not
everywhere consistent. According to the results of this
study, functional status at baseline currently seems to in-
fluence the decision where to refer the patient for rehabili-
tation and patients with the highest need of medical and
social support were referred to most supportive locations.
The tendency to a higher level of functional depend-
ency of patients referred to IR was in accordance with
the literature describing that patients referred to inten-
sive inpatient rehabilitation are older, suffer from more
comorbidities, are living alone and have worse postop-
erative functional status [27–30]. Our results showed
rather weak associations of disability, mobility and co-
morbidities at baseline.
Table 3 WOMAC-scores
Ambulatory treatment Cure Inpatient rehabilitation p at T2
n T0 T2 Δ ES T0 T2 Δ ES T0 T2 Δ ES ΔAT vs.
ΔCure
ΔAT vs.
ΔIR
ΔCure vs.
ΔIR
Global 186 40.9
(19.5)
11.5
(9.5)
−29.4
(20.0)
1.51 48.9
(19.4)
12.7
(10.7)
−36.2
(19.3)
1.87 46.0
(21.2)
18.0
(16.0)
−28.0
(20.3)
1.32 0.037* 0.937 0.052
Pain 198 40.1
(21.2)
9.4
(9.6)
−30.7
(21.4)
1.45 47.9
(22.7)
8.9
(7.9)
−39.0
(23.0)
1.72 44.5
(20.3)
13.6
(16.7)
−30.9
(22.4)
1.53 0.036* 0.448 0.101
Stiffness 197 40.9
(28.1)
14.1
(16.4)
−26.7
(28.5)
0.95 47.7
(25.6)
13.0
(11.2)
−34.6
(26.4)
1.35 47.1
(27.8)
17.7
(21.0)
−29.4
(31.0)
1.06 0.149 0.496 0.605
Function 189 41.5
(20.8)
12.0
(10.6)
−29.5
(21.1)
1.41 49.4
(20.1)
13.7
(12.4)
−35.7
(20.1)
1.78 46.4
(22.9)
19.2
(17.4)
−27.2
(22.2)
1.19 0.067 0.838 0.059
All values are arithmetic mean (standard deviation). WOMAC Western Ontario and McMaster Universities Index ranging from 0 = no symptoms/no limitation to
100 =maximal symptoms/maximal limitation, n number of complete data sets, T0 admission to hospital, AT ambulatory treatment, IR inpatient rehabilitation, T2
6 months follow-up, Δ difference (T2-T0), ES effect size, * statistical significance with p < 0.050
Table 2 Functional mobility
Ambulatory treatment Cure Inpatient rehabilitation p at T0 p at T1
n T0 T1 n T0 T1 n T0 T1 AT vs
Cure
AT vs
IR
Cure vs
IR
AT vs
Cure
AT vs
IR
Cure vs
IR
TUG
(s)
89 11.7
(6.6)
27.5
(18.2)
39 10.8
(3.4)
33.9
(22.0)
52 12.0
(5.1)
40.0
(32.8)
0.910 0.040* 0.085 0.169 0.001* 0.252
ILOAS 87 0.8 (2.4) 12.2 (5.0) 34 0.4 (0.9) 13.9 (6.0) 48 1.5 (3.4) 16.0 (7.0) 0.494 0.202 0.133 0.102 0.000* 0.044*
All values are arithmetic mean (standard deviation). n number of complete data sets, T0 admission to hospital, T1 discharge from hospital (postoperative), TUG
Timed Up and Go, ILOAS Iowa Level of Assistance Scale, s seconds, * statistical significance with p < 0.050
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The second hypothesis could not be verified. Highest
functional score changes were observed in Cure, followed
by AR and IR. This means that high therapy intensity did
not automatically lead to high functional improvements.
This is in accordance with the conclusion that inpatient
rehabilitation compared to home-based rehabilitation did
not lead to a difference in pain or functional outcomes
[31]. Taking into account that the Cure group had the
highest disability scores before treatment, regression to
the mean has to be considered as a possible cause of the
observed changes.
Cure, a special characteristic of the Swiss health sys-
tem, has not been included in the studies mentioned be-
fore [27–30]. In some countries, the difference of factors
influencing the discharge destination after the acute hos-
pital stay was explained by the unequal access to health
services due to different health insurance status [32]. In
Switzerland, all patients have equal access to the health
care system based on the mandatory basic health insur-
ance. Nevertheless, depending on the optional supple-
mentary health care insurances, the fact that the patients
may have to contribute an important part to the cost of
a Cure may prevent postoperative admission to Cure in
some cases.
A systematic review studied the influence of patient
characteristics on the outcome of hip and knee arthro-
plasty in patients with osteoarthritis [33]. Although older
age was related to worse outcome in terms of function,
all groups benefited from joint arthroplasty, independent
of age [33]. In this study, large improvements were
measured in all WOMAC categories as well as in the
WOMAC global score independent of the rehabilitation
modalities and the factors influencing the referral to
the more intensive IR. Internationally, more different
modalities of post-hospital treatment exist than investi-
gated in this study. Based on this study, the decision
where to refer a patient after the acute hospital should
not be based on the therapy intensities and the ex-
pected improvement of rehabilitation.
In the present study, the score changes of three differ-
ent rehabilitation settings for hip and knee arthroplasties
were compared. The high number of patients with only
few drop-outs at follow-up is a strength of the study.
Limitations for this study may arise by the naturalistic
study design. The decision where to refer the patient
after arthroplasty is not based on distinct criteria or
guidelines but based on the subjective assessment of the
orthopaedic surgeon in agreement with the patient and
the willingness to pay of the insurance. This may cause
different kinds of bias such as channelling bias and con-
founding as described in the introduction. While some
potential confounders like comorbidities and age were
measured, others like experience of the surgeon and type
of insurance were not. Limited information about the
exact number of therapies, kind of therapies as well as
the content of therapies and the use of medication is a
limitation of the study. The heterogeneity and variability
of the treatment could not be considered. It is difficult to
standardise the amount and intensity of treatment because
in the setting of elderly and multimorbid subjects therapy
is individually tailored rather than standardized. This leads
to a high variability and heterogeneity of treatments and
the corresponding score changes. No examiner-rated mea-
sures were available at follow-up to validate self-reported
improvements as indicated by WOMAC.
Conclusions
We conclude that severely impaired patients were ad-
mitted to the postoperative treatment with the highest
therapy intensity, i.e. inpatient rehabilitation and Cure.
Highest health improvements 6 months after arthroplasty
were not necessarily associated with higher therapy inten-
sity. Patients referred to intensive inpatient rehabilitation
were older, had more comorbidities and the most im-
paired mobility which may have affected health-changes
in the mid-term.
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